To further validate whether siGRP78-mediated apoptosis implicated AKT-mTOR signal pathway, AKT activator SC79 was used to treat BPH-1 and WPMY-1 cells transfected with/without GRP78 siRNA. Here, AKT1 is linked to benign prostatic hyperplasia.